Cervical Cancer Screening Market to Reach USD 16.8 Billion by 2031,...

Autres

Cervical Cancer Screening Market to Reach USD 16.8 Billion by 2031, Driven by HPV Testing and AI-Enhanced Cytology

2025-06-20 13:20:53 • Visualizações

[Geneva, 20 June 2025] – The global cervical cancer screening market is projected to grow from USD 10.12 billion in 2024 to USD 16.84 billion by 2031, with a CAGR of 7.5%, according to Clearview Market Insights (CVMI).

“With HPV DNA tests offering better sensitivity and AI-based cytology improving diagnostic efficiency, countries are moving rapidly toward scalable, quality screening,” said Dr. Serena Bianchi, CVMI’s Director of Oncology Diagnostics.

Request Sample @ https://clearviewmarketinsights.com/report-details/global-cervical-cancer-screening-market/

Growth Highlights:

HPV DNA test adoption increasing in North America, Europe, and select APAC markets
Self-sampling kits and mobile screening vans enhancing rural access
Hologic, Roche, and Qiagen driving innovation in diagnostics automation
WHO programs backing cervical cancer elimination efforts in 85+ nations

Segment Insights:

HPV DNA screening is now replacing Pap smear tests and comprises over 42% of the market share. While VIA testing continues in rural outreach programs, it faces limitations in sensitivity and standardization.

Regional Outlook:

Europe and North America are at the forefront of AI-enabled cytology and co-testing. The Asia-Pacific region is advancing rapidly, bolstered by India’s National Cervical Cancer Elimination Plan and China’s 2024 HPV DNA subsidy. Latin America and Sub-Saharan Africa are implementing hybrid models that combine self-sampling with mobile labs.

Innovation Watch:

Hologic’s Genius Digital Diagnostics system improves AI-slide triage
Qiagen expands rapid HPV kits for field testing
Roche deploys CINtec with p16/Ki-67 markers in multi-country trials

Outlook to 2031:
By 2031, more than 60% of global screenings will transition to molecular-based platforms. The integration of home-based kits and mobile diagnostics will increase LMIC coverage to over 50%, moving the world closer to WHO’s vision of elimination.

For more insights, visit https://clearviewmarketinsights.com/

About Clearview Market Insights:

Clearview Market Insights is a leading market research and consulting firm providing in-depth industry analysis and strategic recommendations for businesses worldwide.

Media contact:

Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369

Faça o login para curtir, compartilhar e comentar!

Cervical Cancer Screening Market to Reach USD 16.8 Billion by 2031, Driven by HPV Testing and AI-Enhanced Cytology

The Golden Spice: Saffron Industry Trends 2023-2029

Lead Market to Hit $29.0 Billion By 2030

Acessar

Idiomas

Cervical Cancer Screening Market to Reach USD 16.8 Billion by 2031, Driven by HPV Testing and AI-Enhanced Cytology

The Golden Spice: Saffron Industry Trends 2023-2029

Lead Market to Hit $29.0 Billion By 2030